Impact of Endogenous E2 on SSI and GH Rebound

Clinical trial NCT02026973 · COMPLETED

Trial details

NCT number: NCT02026973
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Normal Healthy Volunteers

Start date: 2014-03-01
Primary completion: 2015-11-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.